VTVT NASDAQ
vTv Therapeutics Inc.
1W: +1.2%
1M: -8.5%
3M: -11.5%
YTD: -22.8%
1Y: +27.4%
3Y: +68.7%
5Y: -56.8%
$30.57
-1.28 (-4.02%)
Weekly Expected Move ±4.9%
$28
$29
$31
$32
$34
Overview
News
Chart
Smart Money
Financials
Income Statement
Cash Flow
Balance Sheet
Earnings
Dividends
Analysis
Technicals
Weather
Peers
ESG
Institutions
ETF Exposure
Dark Pool
Short Interest
Supply Chain
Supply Chain Overview
11 relationships11
As Filer
counterparties named
0
As Counterparty
mentioned by others
4
Rel. Types
2022-07-25
Earliest Filing
2026-02-02
Latest Filing
investor: 6
partner: 3
licensee: 1
customer: 1
Counterparties (Filed by VTVT)
11 relationshipsCompanies named in VTVT's SEC 8-K filings as business counterparties.
| Counterparty | Ticker | Relationship | Summary | Filing Date | SEC |
|---|---|---|---|---|---|
| Newsoara Biopharma Co., Ltd. | — | partner | Second Amendment to License Agreement expanding rights to HPP737 globally upon upfront fee and milestone payments. | 2026-02-02 | View |
| Newsoara Biopharma Co., Ltd. | — | licensee | Entered into a Second Amendment to License Agreement to expand the original license globally upon payment of an upfront | 2024-07-02 | View |
| Cowen and Company, LLC | — | partner | Sales agent for ATM Offering of Class A common stock | 2024-02-28 | View |
| Cantor Fitzgerald & Co. | — | partner | Previous sales agent for Controlled Equity Offering program | 2024-02-28 | View |
| G42 Investments AI Holdings RSC Ltd | — | investor | Investor in private placement; amendment to registration rights and board designation rights. | 2024-02-28 | View |
| CinPax, LLC | — | investor | Investor in private placement; amendment to registration rights and board designation rights. | 2024-02-28 | View |
| CinRx Pharma, LLC | — | investor | Investor in private placement; amendment to registration rights and board observer rights. | 2024-02-28 | View |
| M&F TTP Holdings Two LLC | — | investor | Investor in private placement; successor to vTv Therapeutics Holdings LLC; amendment to registration rights and board de | 2024-02-28 | View |
| Reneo Pharmaceuticals, Inc. | — | customer | Reneo agreed to purchase all shares of common stock of Reneo owned by vTv LLC for approximately $4.4 million. | 2023-11-01 | View |
| CinPax, LLC | — | investor | Purchased 4,154,549 shares of common stock and a promissory note for $10,000,000 | 2022-07-25 | View |
| CinRx Pharma, LLC | — | investor | Purchased warrants to purchase up to 1,200,000 shares of common stock | 2022-07-25 | View |
Recent 8-K Filings (20)
| Filing Date | Description | Type | SEC |
|---|---|---|---|
| 2026-08-06 | Earnings Release; Exhibits | View | |
| 2026-06-29 | Shareholder Vote | View | |
| 2026-05-13 | Earnings Release; Exhibits | View | |
| 2026-05-13 | Other Events; Exhibits | View | |
| 2026-03-10 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2026-03-10 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-26 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2026-02-02 | Entry into Material Definitive Agreement | Agreement | View |
| 2025-12-19 | Amendments to Articles of Incorporation or Bylaws; Financial Statements and Exhibits | View | |
| 2025-11-06 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-09-10 | Regulation FD Disclosure | View | |
| 2025-09-02 | Entry into Material Definitive Agreement; Financial Statements and Exhibits | Agreement | View |
| 2025-08-12 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-06-12 | Submission of Matters to a Vote of Security Holders | View | |
| 2025-05-19 | Departure/Election of Directors; Appointment of Officers; Financial Statements and Exhibits | View | |
| 2025-05-16 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-05-15 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View | |
| 2025-04-11 | Departure/Election of Directors; Appointment of Officers | View | |
| 2025-03-31 | Regulation FD Disclosure; Financial Statements and Exhibits | View | |
| 2025-03-20 | Results of Operations and Financial Condition; Financial Statements and Exhibits | View |
Data extracted from SEC EDGAR 8-K filings using NLP. Relationships are as disclosed in filing text.
Covers 2021–2026. View on SEC EDGAR